ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 693

Hair Chemicals and Systemic Lupus Erythematosus: A Case-Control Study

Jessica English1, Trevor Faith 2, Dulaney Wilson 1 and Diane Kamen 3, 1Medical University of South Carolina, Charleston, SC, 2Medical University of South Carolina, Charleston, 3Division of Rheumatology and Immunology, Department of Medicine, Medical University of South Carolina, Charleston, South Carolina, USA., Charleston, SC

Meeting: 2019 ACR/ARP Annual Meeting

Keywords: auto-immunity and young investigators, Environmental factors, hair, SLE

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 10, 2019

Title: SLE – Clinical Poster I: Epidemiology & Pathogenesis

Session Type: Poster Session (Sunday)

Session Time: 9:00AM-11:00AM

Background/Purpose: Systemic lupus erythematosus (SLE) is a complex chronic autoimmune disease of unknown etiology. Previous studies of beauty products as potential triggers of SLE development have shown conflicting results. Our study evaluates the use of hair chemicals in patients with SLE and controls and the relationship of use with disease severity among patients.

Methods: Data was obtained from an ongoing longitudinal registry of patients with SLE and non-SLE population-matched controls at a single center. Participants seen over a 12 year period. Information on demographics, medical history, social history, types of hair chemicals used, and SLE characteristics (if applicable) was gathered from in-person interviews. Chart review and telephone follow-up was done for missing values. Disease damage was determined by SLICC/ACR Damage Index (“damage present” if score ≥1). Males and children were excluded from the study population. “Cutaneous lupus” includes SLE patients with documented malar rash, discoid rash, photosensitivity, and/or alopecia. Pearson’s chi-squared testing was performed for categorical measures and two-sample t-tests were performed for continuous measures. Significance was set at alpha = 0.05.

Results: A total of 359 female SLE patients and 175 female controls were included, Table 1. Hair chemical use was more frequent in self-identified black patients (p< 0.01). Patients with SLE were significantly more likely to use hair chemicals compared to controls (65.5% vs. 49.7%, p< 0.01), specifically with higher proportions of patients using hair relaxers/straighteners (p=0.91), hair dyes (p=0.07), and permanent wave products (p=0.23). SLE damage did not differ among patients who use hair chemicals compared to non-users (p=0.97), Table 2. A higher percentage of hair chemical users had cutaneous manifestations, but was not statistically significant (p=0.10)

Conclusion: In conclusion, we found that hair chemical use among females was significantly higher in patients with SLE compared to controls, especially hair dyes. These results provide a basis to look further in to hair chemical use and its relation to autoimmunity. Ongoing analyses are examining the timing and duration of hair chemical use and the development of autoimmunity. 


Table 1

Table 1. Group Characteristics


Table 2

Table 2. Disease Characteristics


Disclosure: J. English, None; T. Faith, None; D. Wilson, None; D. Kamen, None.

To cite this abstract in AMA style:

English J, Faith T, Wilson D, Kamen D. Hair Chemicals and Systemic Lupus Erythematosus: A Case-Control Study [abstract]. Arthritis Rheumatol. 2019; 71 (suppl 10). https://acrabstracts.org/abstract/hair-chemicals-and-systemic-lupus-erythematosus-a-case-control-study/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2019 ACR/ARP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/hair-chemicals-and-systemic-lupus-erythematosus-a-case-control-study/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology